In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Moore, Daniel J ^a,b   Zienkiewicz, Jozef ^a   Kendall, Peggy L ^b   Liu, Danya ^a,c   Liu, Xueyan ^a   Veach, Ruth Ann ^a   Collins, Robert D ^b   Hawiger, Jacek ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYCLOPHOSPHAMIDE; CYTOKINE; N 50; NON CELL PENETRATING PEPTIDE; PEPTIDE; SN 50; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; INTERLEUKIN 11; INTERLEUKIN 5;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL DEATH; CELL DESTRUCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; HYPOTHESIS; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEAR IMPORT; PANCREAS ISLET; PANCREAS ISLET BETA CELL; STRESS; T LYMPHOCYTE; ANIMAL; CELL NUCLEUS; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; CELL NUCLEUS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; IMMUNITY, INNATE; INTERLEUKIN-11; INTERLEUKIN-5; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; SIGNAL TRANSDUCTION;

EID: 78049308002     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013235     Document Type: Article

References (57)

1. Huang X, Moore DJ, Ketchum RJ, Nunemaker CS, Kovatchev B, et al. (2008) Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev 29: 603-630.
2. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, et al. (2002) Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346: 1692-1698.
3. Hu CY, Rodriguez-Pinto D, Du W, Ahuja A, Henegariu O, et al. (2007) Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J Clin Invest 117: 3857-3867.
4. Xiu Y, Wong CP, Bouaziz JD, Hamaguchi Y, Wang Y, et al. (2008) B Lymphocyte Depletion by CD20 Monoclonal Antibody Prevents Diabetes in Nonobese Diabetic Mice despite Isotype-Specific Differences in Fc{gamma}R Effector Functions. J Immunol 180: 2863-2875.
5. Skyler JS (2008) Update on worldwide efforts to prevent type 1 diabetes. Ann N Y Acad Sci 1150: 190-196.
6. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, et al. (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361: 2143-2152.
7. Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, et al. (2005) A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 54: 1763-1769.
8. Koulmanda M, Budo E, Bonner-Weir S, Qipo A, Putheti P, et al. (2007) Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts. Proc Natl Acad Sci U S A 104: 13074-13079.
9. Koulmanda M, Bhasin M, Hoffman L, Fan Z, Qipo A, et al. (2008) Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A 105: 16242-16247.
10. Louvet C, Szot GL, Lang J, Lee MR, Martinier N, et al. (2008) Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A 105: 18895-18900.
11. Yang ZD, Chen M, Wu R, McDuffie M, Nadler JL (2002) The antiinflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice. Diabetologia 45: 1307-1314.
12. Noorchashm H, Moore DJ, Lieu YK, Noorchashm N, Schlachterman A, et al. (1999) Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell Immunol 195: 75-79.
13. Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT (1996) Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes 45: 1253-1258.
14. Mangge H, Schauenstein K, Stroedter L, Griesl A, Maerz W, et al. (2004) Low grade inflammation in juvenile obesity and type 1 diabetes associated with early signs of atherosclerosis. Exp Clin Endocrinol Diabetes 112: 378-382.
15. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113.
16. Lee KU, Amano K, Yoon JW (1988) Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37: 989-991.
17. Foulis AK, McGill M, Farquharson MA (1991) Insulitis in type 1 (insulindependent) diabetes mellitus in man-macrophages, lymphocytes, and interferongamma containing cells. J Pathol 165: 97-103.
18. Pasare C, Medzhitov R (2004) Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21: 733-741.
19. Thornley TB, Brehm MA, Markees TG, Shultz LD, Mordes JP, et al. (2006) TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol 176: 1561-1570.
20. D'Alise AM, Auyeung V, Feuerer M, Nishio J, Fontenot J, et al. (2008) The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc Natl Acad Sci U S A 105: 19857-19862.
21. You S, Belghith M, Cobbold S, Alyanakian MA, Gouarin C, et al. (2005) Autoimmune diabetes onset results from qualitative rather than quantitative agedependent changes in pathogenic T-cells. Diabetes 54: 1415-1422.
22. Eizirik DL, Mandrup-Poulsen T (2001) A choice of death-the signaltransduction of immune-mediated beta-cell apoptosis. Diabetologia 44: 2115-2133.
23. Hayashi T, Faustman D (1999) NOD mice are defective in proteasome production and activation of NF-kappaB. Mol Cell Biol 19: 8646-8659.
24. Eldor R, Yeffet A, Baum K, Doviner V, Amar D, et al. (2006) Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci U S A 103: 5072-5077.
25. Liuwantara D, Elliot M, Smith MW, Yam AO, Walters SN, et al. (2006) Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes 55: 2491-2501.
26. Poligone B, Weaver DJ, Jr., Sen P, Baldwin AS, Jr., Tisch R (2002) Elevated NFkappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J Immunol 168: 188-196.
27. Sen P, Bhattacharyya S, Wallet M, Wong CP, Poligone B, et al. (2003) NFkappa B hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages. J Immunol 170: 1770-1780.
28. Wheat W, Kupfer R, Gutches DG, Rayat GR, Beilke J, et al. (2004) Increased NF-kappa B activity in B cells and bone marrow-derived dendritic cells from NOD mice. Eur J Immunol 34: 1395-1404.
29. Salojin KV, Zhang J, Madrenas J, Delovitch TL (1998) T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease. Immunology Today 19: 468-473.
30. Noorchashm H, Moore DJ, Noto LE, Noorchashm N, Reed AJ, et al. (2000) Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol 165: 4685-4696.
31. Greeley SA, Moore DJ, Noorchashm H, Noto LE, Rostami SY, et al. (2001) Impaired activation of islet-reactive CD4 T cells in pancreatic lymph nodes of B cell-deficient nonobese diabetic mice. J Immunol 167: 4351-4357.
32. Arreaza G, Salojin K, Yang W, Zhang J, Gill B, et al. (2003) Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin Immunol 107: 103-115.
33. Hussain S, Salojin KV, Delovitch TL (2004) Hyperresponsiveness, resistance to B-cell receptor-dependent activation-induced cell death, and accumulation of hyperactivated B-cells in islets is associated with the onset of insulitis but not type 1 diabetes. Diabetes 53: 2003-2011.
34. Hawiger J (2001) Innate immunity and inflammation: a transcriptional paradigm. Immunol Res 23: 99-109.
35. Hussain S, Delovitch TL (2005) Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. J Immunol 174: 680-687.
36. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270: 14255-14258.
37. Torgerson TR, Colosia AD, Donahue JP, Lin YZ, Hawiger J (1998) Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NFkappa B p50. J Immunol 161: 6084-6092.
38. Liu X, Robinson D, Veach RA, Liu D, Timmons S, et al. (2000) Peptidedirected suppression of a pro-inflammatory cytokine response. J Biol Chem 275: 16774-16778.
39. Liu D, Li C, Chen Y, Burnett C, Liu XY, et al. (2004) Nuclear import of proinflammatory transcription factors is required for massive liver apoptosis induced by bacterial lipopolysaccharide. J Biol Chem 279: 48434-48442.Epub 42004 Sep 48431.
40. Liu D, Zienkiewicz J, DiGiandomenico A, Hawiger J (2009) Suppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitor. Mol Ther 17: 796-802.
41. Baxter AG, Mandel TE (1991) Accelerated diabetes in non-obese diabetic (NOD) mice differing in incidence of spontaneous disease. Clin Exp Immunol 85: 464-468.
42. Chatenoud L, Thervet E, Primo J, Bach JF (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A 91: 123-127.
43. Ablamunits V, Quintana F, Reshef T, Elias D, Cohen IR (1999) Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFNgamma secretion pathway. J Autoimmun 13: 383-392.
44. Matos M, Park R, Mathis D, Benoist C (2004) Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. Diabetes 53: 2310-2321.
45. Signore A, Procaccini E, Toscano AM, Ferretti E, Williams AJ, et al. (1994) Histological study of pancreatic beta-cell loss in relation to the insulitis process in the non-obese diabetic mouse. Histochemistry 101: 263-269.
46. Liu D, Liu XY, Robinson D, Burnett C, Jackson C, et al. (2004) Suppression of Staphylococcal Enterotoxin B-induced Toxicity by a Nuclear Import Inhibitor. J Biol Chem 279: 19239-19246.Epub 12004 Jan 19219.
47. Suk K, Kim S, Kim YH, Kim KA, Chang I, et al. (2001) IFN-gamma/TNFalpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol 166: 4481-4489.
48. Papaccio G, Graziano A, D'Aquino R, Valiante S, Naro F (2005) A biphasic role of nuclear transcription factor (NF)-kappaB in the islet beta-cell apoptosis induced by interleukin (IL)-1beta. J Cell Physiol 204: 124-130.
49. Rasschaert J, Ladriere L, Urbain M, Dogusan Z, Katabua B, et al. (2005) Tolllike receptor 3 and STAT-1 contribute to double-stranded RNA+ interferongamma- induced apoptosis in primary pancreatic beta-cells. J Biol Chem 280: 33984-33991.
50. Theodore M, Kawai Y, Yang J, Kleshchenko Y, Reddy SP, et al. (2008) Multiple nuclear localization signals function in the nuclear import of the transcription factor Nrf2. J Biol Chem 283: 8984-8994.
51. Veach RA, Liu D, Yao S, Chen Y, Liu XY, et al. (2004) Receptor/transporterindependent targeting of functional peptides across the plasma membrane. J Biol Chem 279: 11425-11431.Epub 12003 Dec 11429.
52. Ramamoorthy A, Kandasamy SK, Lee DK, Kidambi S, Larson RG (2007) Structure, topology, and tilt of cell-signaling peptides containing nuclear localization sequences in membrane bilayers determined by solid-state NMR and molecular dynamics simulation studies. Biochemistry 46: 965-975.
53. Webb SR, Hutchinson J, Hayden K, Sprent J (1994) Expansion/deletion of mature T cells exposed to endogenous superantigens in vivo. J Immunol 152: 586-597.
54. Serreze DV, Chapman HD, Post CM, Johnson EA, Suarez-Pinzon WL, et al. (2001) Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol 166: 1352-1359.
55. Li FX, Zhu JW, Tessem JS, Beilke J, Varella-Garcia M, et al. (2003) The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc Natl Acad Sci U S A 100: 12935-12940.
56. Kendall PL, Woodward EJ, Hulbert C, Thomas JW (2004) Peritoneal B cells govern the outcome of diabetes in non-obese diabetic mice. Eur J Immunol 34: 2387-2395.
57. Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, et al. (1999) Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189: 331-339.